Franziska Horling has a diverse background in genetics, with a Ph.D. and post-doctorate degree from The Julius Maximilians University of Würzburg. Franziska has held various positions in gene therapy and research and development at companies such as Evotec, Takeda, Shire, Baxalta, and Baxter. Currently, Franziska serves as a Senior Project Manager and Senior Research Scientist at Evotec, where Franziska also leads a group in Vectorology for gene therapy. With a strong foundation in biology and genetics, Franziska has a wealth of experience in scientific writing, cell line development, vector design, and project management.
February, 2022 - present
September, 2020
April, 2020